Zurich: Swiss agency for therapeutic products, SwissMedic on Friday approved the use of the Pfizer vaccine for children aged 5-11.
“SwissMedic has carefully checked all data delivered with the application for an indication extension for Covid-19 vaccine from Pfizer / Bionth (Comirdnaty®).
The results of clinical trials show that this vaccine is safe and effective in this age group …
thus It would be possible for children aged 5 years and over to be vaccinated against the new Coronavirus (SARS-COV-2) in accordance with the recommendations of the updated federal government vaccination, “SwissMedic said in a statement on its website.
The agency said research involving more than 1,500 participants showed that vaccines provide almost complete protection for children aged 5-11 against Covid-19.
Agency adds that side effects include pain in injection or fatigue, sometimes headaches, legilities of the leg and fever.
According to the latest data, 66 percent of Swiss citizens have been fully vaccinated against Covid-19.